Biotech & MedTech News
-
Hemostemix Announces the Appointment of Dr. Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board
September 14, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) is pleased to announce…
-
Hemostemix Announces Its Presentation to the Emerging Growth Conference
September 14, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) invites individuals,…
-
Valeo Pharma Enters into Canadian Commercial Services Agreement with Veru for Sabizabulin in Hospitalized Adult Patients with Covid-19 at High Risk for Acute Respiratory Distress Syndrome (ARDS)
In a Phase 3 cinical study interim analysis, sabizabulin showed a 55.2% reduction in deaths compared to placebo…
-
Valeo Pharma Reports Record Third Quarter 2022 Results and Highlights
Record revenues of $6.1 million in Q3-22, a 27% increase over Q2-22 Record Gross Margins of $2.2 million in Q3-22,…
-
Sixth Wave and Magnus Mineral Resources (PVT) Ltd Sign USD$50M+ Contract for Implementation of IXOS(R) Mining Technology at the Penhalonga Gold Mine and Beyond
September 12, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave” or “SIXW” or…
-
Awakn Life Sciences Signs Drug Development Agreement with Catalent for Zydis(R) Technology (An Orally Disintegrating Tablet) to Conduct Feasibility Studies to Improve Differentiation of Its MDMA Program
September 12, 2022 (Source) – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a revenue-generating biotechnology…
-
Valeo Pharma to Host Third Quarter 2022 Results Conference Call / Webcast
September 9, 2022 (Source) – Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Zentek Announces Annual General Meeting on Thursday September 29th, 2022, at the Delta Hotel in Guelph, Ontario
September 8, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is…
-
Zentek Announces Manufacturing and Supply Agreement with Viva Healthcare Packaging (Canada) Ltd. to Manufacture and Sell ZenGUARD(TM)- Enhanced Surgical Masks
September 7, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK; TSX-V:ZEN), an intellectual property development and commercialization company,…
-
Hemostemix Announces A Clarification
August 31, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) received numerous…
